Abstract
Background
Preventive treatment for refractory chronic cluster headache (rCCH) is challenging and many therapies have been tried.
Objective
To study what could be considered the therapy of choice in rCCH through a systematic review and meta-analysis.
Methods
This review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The protocol was registered in PROSPERO (ID CRD42021290983). A systematic search was performed in MEDLINE, Embase, Cochrane, clinicaltrials.gov, and the WHO’s-International-Clinical-Trials-Registry-Platform. Studies on the preventive treatment for rCCH as defined by the European Headache Federation consensus statement were included. A meta-analysis of the pooled response rate was conducted for the different therapies.
Results
Of 336 results, 45 were eligible for inclusion. Most articles studied the effect of neuromodulation as a preventive treatment for rCCH. The most studied neuromodulation technique was occipital nerve stimulation (ONS), with a pooled response rate in the meta-analysis of 57.3% (95% CI 0.481–0.665). Deep brain stimulation (DBS) was the second most studied treatment with a pooled response rate of 77.0% (95% CI 0.594–0.957). DBS results were more heterogeneous than ONS, which could be related to the different stimulation targets in DBS studies, and reported more serious adverse events than in ONS studies. The remaining therapies (anti-CGRP pathway drugs, warfarin, ketamine-magnesium infusions, serial occipital nerve blocks, clomiphene, onabotulinum toxin A, ketogenic diet, sphenopalatine ganglion radiofrequency or stimulation, vagus nerve stimulation, percutaneous bioelectric current stimulation, upper cervical cord stimulation, and vidian neurectomy) present weaker results or have less quality of evidence.
Conclusions
The results of this systematic review and meta-analysis suggest that ONS could be the first therapeutic strategy for patients with rCCH based on the current evidence.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
References
Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1–211
Fischera M, Marziniak M, Gralow I, Evers S (2008) The incidence and prevalence of cluster headache: a meta-analysis of population-based studies. Cephalalgia 28:614–618
Hoffmann J, May A (2018) Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol 17:75–83
Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ (2016) Treatment of cluster headache: the American headache society evidence-based guidelines. Headache 56:1093–1106
Mitsikostas DD et al (2014) Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. J Headache Pain 15:79
D’Amico D, Raggi A, Grazzi L, Lambru G (2020) Disability, quality of life, and socioeconomic burden of cluster headache: a critical review of current evidence and future perspectives. Headache 60:809–818
Jensen R, Lyngberg A, Jensen R (2007) Burden of cluster headache. Cephalalgia 27:535–541
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535–b2535
Dodick DW et al (2020) Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: results from 3-month double-blind treatment. Cephalalgia 40:935–948
Ruscheweyh R et al (2020) Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: results from a retrospective case series support individual treatment attempts. Cephalalgia 40:1574–1584
Hakim SM (2011) Warfarin for refractory chronic cluster headache: a randomized pilot study. Headache 51:713–725
Brandt RB et al (2021) Repeated greater occipital nerve injections with corticosteroids in medically intractable chronic cluster headache: a retrospective study. Neurol Sci. https://doi.org/10.1007/s10072-021-05399-5
Aurora S et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30:793–803
Lampl C, Mirjam R (2016) Botulinum Toxin a in the treatment of refractory chronic cluster headache—a pilot study. Cephalalgia 36:99
Crespi J et al (2020) Open-label, multi-dose, pilot safety study of injection of onabotulinumtoxina toward the Otic ganglion for the treatment of intractable chronic cluster headache. Headache 60:1632–1643
Aschehoug I, Bratbak DF, Tronvik EA (2018) Long-term outcome of patients with intractable chronic cluster headache treated with injection of onabotulinum toxin A toward the sphenopalatine ganglion—an observational study. Headache 58:1519–1529
Khatami R, Tartarotti S, Siccoli MM, Bassetti CL, Sandor PS (2011) Long-term efficacy of sodium oxybate in 4 patients with chronic cluster headache. Neurology 77:67–70
Nobre ME, Peres MFP, Moreira PFF, Leal AJ (2017) Clomiphene treatment may be effective in refractory episodic and chronic cluster headache. Arq Neuropsiquiatr 75:620–624
Moisset X, Clavelou P, Lauxerois M, Dallel R, Picard P (2017) Ketamine infusion combined with magnesium as a therapy for intractable chronic cluster headache: report of two cases. Headache 57:1261–1264
Moisset X et al (2020) Ketamine-magnesium for refractory chronic cluster headache: a case series. Headache 60:2537–2543
Wilbrink LA et al (2021) Safety and efficacy of occipital nerve stimulation for attack prevention in medically intractable chronic cluster headache (ICON): a randomised, double-blind, multicentre, phase 3, electrical dose-controlled trial. Lancet Neurol 20:515–525
Leone M, ProiettiCecchini A, Messina G, Franzini A (2017) Long-term occipital nerve stimulation for drug-resistant chronic cluster headache. Cephalalgia 37:756–763
Díaz-de-Terán J et al (2021) Occipital nerve stimulation for pain modulation in drug-resistant chronic cluster headache. Brain Sci 11:236
Leplus A et al (2021) Long-term efficacy of occipital nerve stimulation for medically intractable cluster headache. Neurosurgery 88:375–383
Magis D, Gerardy P-Y, Remacle J-M, Schoenen J (2011) Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache. Headache 51:1191–1201
Miller S, Watkins L, Matharu M (2017) Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients. Eur J Neurol 24:381–390
Burns B, Watkins L, Goadsby PJ (2009) Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 72:341–345
Fontaine D et al (2011) Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation. Cephalalgia 31:1101–1105
Magis D et al (2007) Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 6:314–321
Aibar-Durán JÁ et al (2021) Occipital nerve stimulation and deep brain stimulation for refractory cluster headache: a prospective analysis of efficacy over time. J Neurosurg 134:393–400
Belvis R et al (2020) Efficacy and safety of surgical treatment of cluster headache. Med Clin (Barc) 154:75–79
Dzhafarov VM, Slavin KV (2021) Simultaneous sphenopalatine and occipital nerve stimulation in treatment of chronic refractory cluster headache: a case report. Neuromodulation. https://doi.org/10.1111/ner.13470
Fontaine D et al (2010) Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. J Headache Pain 11:23–31
Leone M, Franzini A, Cecchini AP, Bussone G (2013) Success, failure, and putative mechanisms in hypothalamic stimulation for drug-resistant chronic cluster headache. Pain 154:89–94
Fontaine D et al (2010) Anatomical location of effective deep brain stimulation electrodes in chronic cluster headache. Brain 133:1214–1223
Schoenen J (2005) Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain 128:940–947
Cappon D et al (2019) Ventral tegmental area deep brain stimulation for chronic cluster headache: effects on cognition, mood, pain report behaviour and quality of life. Cephalalgia 39:1099–1110
Akram H et al (2016) Ventral tegmental area deep brain stimulation for refractory chronic cluster headache. Neurology 86:1676–1682
Akram H et al (2017) Optimal deep brain stimulation site and target connectivity for chronic cluster headache. Neurology 89:2083–2091
Seijo-Fernandez F et al (2018) Long-term results of deep brain stimulation of the mamillotegmental fasciculus in chronic cluster headache. Stereotact Funct Neurosurg 96:215–222
Schoenen J et al (2013) Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia 33:816–830
Goadsby PJ et al (2019) Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial. Lancet Neurol 18:1081–1090
Nesbitt AD, Marin JCA, Tompkins E, Ruttledge MH, Goadsby PJ (2015) Initial use of a novel noninvasive vagus nerve stimulator for cluster headache treatment. Neurology 84:1249–1253
Gaul C et al (2015) Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): a randomised controlled study. Cephalalgia 36:534–546
Molsberger A, McCaig CD (2020) Percutaneous bioelectric current stimulation for chronic cluster headache—a possible transformative approach to cluster headache. J pain Res 13:817–828. https://doi.org/10.2147/JPR.S242093
Wolter T, Kiemen A, Kaube H (2011) High cervical spinal cord stimulation for chronic cluster headache. Cephalalgia 31:1170–1180
Lazzari ZT, Palmisani S, Hill B, Al-Kaisy A, Lambru G (2020) A prospective case series of sphenopalatine ganglion pulsed radiofrequency therapy for refractory chronic cluster headache. Eur J Neurol 27:1190–1196
Chen Z, Ren H, Zhao C, Luo F (2020) Long-term outcomes of computerized tomography-guided sphenopalatine ganglion-targeted pulsed radiofrequency for refractory cluster headache. Pain Pract 20:289–296
Salgado-López L et al (2019) Efficacy of sphenopalatine ganglion radiofrequency in refractory chronic cluster headache. World Neurosurg 122:e262–e269
Guo Y et al (2021) Low-temperature plasma radiofrequency ablation for the management of refractory cluster headache. Wideochir Inne Tech Maloinwazyjne 16:362–368
Narouze S, Kapural L, Casanova J, Mekhail N (2009) Sphenopalatine ganglion radiofrequency ablation for the management of chronic cluster headache. Headache 49:571–577
Kelderman T, Vanschoenbeek G, Crombez E, Paemeleire K (2019) Safety and efficacy of percutaneous pulsed radiofrequency treatment at the C1–C2 level in chronic cluster headache: a retrospective analysis of 21 cases. Acta Neurol Belg 119:601–605
Liu S-C, Kao M-C, Huang Y-C, Su W-F (2019) Vidian neurectomy for management of chronic cluster headache. Neurosurgery 84:1059–1064
di Lorenzo C et al (2018) Efficacy of modified Atkins ketogenic diet in chronic cluster headache: an open-label, single-arm, clinical trial. Front Neurol 9:64
Fontaine D, Lanteri-Minet M (2021) Occipital nerve stimulation for chronic cluster headache. Lancet Neurol 20:498–499
Mueller O et al (2013) Occipital nerve stimulation for intractable chronic cluster headache or migraine: a critical analysis of direct treatment costs and complications. Cephalalgia 33:1283–1291
Bulsei J et al (2021) Occipital nerve stimulation for refractory chronic cluster headache: a cost-effectiveness study. Neuromodulation 24:1083–1092
Seijo-Fernandez F et al (2011) Review of the target for the deep brain stimulation of chronic cluster headache. Rev Neurol 52:366–370
Goadsby PJ et al (2019) Trial of galcanezumab in prevention of episodic cluster headache. N Engl J Med 381:132–141
Vollesen ALH et al (2018) Effect of infusion of calcitonin gene-related peptide on cluster headache attacks. JAMA Neurol 75:1187
Bussone G et al (1990) Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 30:411–417
Steiner T, Hering R, Couturier E, Davies P, Whitmarsh T (1997) Double-blind placebo-controlled trial of lithium in episodic cluster headache. Cephalalgia 17:673–675
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH). ClinicalTrials.gov Identifier: NCT02964338. Posted September 18, 2019. Accessed September 9, 2021. https://clinicaltrials.gov/ct2/show/NCT02964338
Lipton RB et al (1995) Guidelines for controlled trials of drugs in cluster headache. Cephalalgia 15:452–45262
Dodick DW et al (2022) Challenges and complexities in designing cluster headache prevention clinical trials: a narrative review. Headache 62:453–472
Acknowledgements
To Blanca Fuentes for her guidance.
Funding
The authors did not receive financial or non-financial support or funding for this review.
Author information
Authors and Affiliations
Contributions
All authors made substantial contributions to the conception and study design and data collection. JAM wrote the protocol of the systematic review, performed the search, and wrote the final draft. In the screening and study selection, JAM. and JDT performed the abstract and full-text reading. JR performed the quality assessment. JDT critically revised for important intellectual content. All authors finally approved the version to be published and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflicts of interest to declare.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Membrilla, J.A., Roa, J. & Díaz-de-Terán, J. Preventive treatment of refractory chronic cluster headache: systematic review and meta-analysis. J Neurol 270, 689–710 (2023). https://doi.org/10.1007/s00415-022-11436-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-022-11436-w